FDA Approves Futibatinib for Certain Biliary Tract Cancers ...Middle East

Medscape - News
The indication is for use in adult patients with previously treated intrahepatic cholangiocarcinoma harboring fibroblast growth factor receptor 2 (FGFR2) gene fusions or other rearrangements. FDA Approvals

Hence then, the article about fda approves futibatinib for certain biliary tract cancers was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Approves Futibatinib for Certain Biliary Tract Cancers )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News